irinotecan has been researched along with Leukemia, Promyelocytic, Acute in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Chiang, JH; Chueh, FS; Chung, JG; Hsueh, SC; Lee, CS; Lu, CC; Lu, HF; Yang, JS | 1 |
| Cahn, JY; Merrouche, Y; Mugneret, F | 1 |
| Nakamura, T; Ueda, T; Wano, Y; Yoshida, A | 1 |
3 other study(ies) available for irinotecan and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Camptothecin; Caspase 3; Cell Cycle Proteins; Disease Models, Animal; DNA Damage; Endoplasmic Reticulum Chaperone BiP; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Irinotecan; Leukemia, Promyelocytic, Acute; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Transplantation, Heterologous | 2015 |
Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Female; Humans; Irinotecan; Leukemia, Promyelocytic, Acute; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin | 2006 |
DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells.
Topics: Camptothecin; Cell Death; DNA Damage; DNA Repair; DNA, Neoplasm; DNA, Single-Stranded; Humans; Irinotecan; Leukemia, Promyelocytic, Acute; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Zinc | 1993 |